Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 22, 2016
Health Utilities for Multiple Sclerosis
Annie Hawton, Colin Green
Pharmacoeconomics - Open
|
February 15, 2018
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
Jeff Round, Annie Hawton
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 23, 2017
"Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis
Colin Green, Elizabeth Goodwin, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 17, 2018
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P)
Elizabeth Goodwin, Colin Green, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 2, 2020
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis
Elizabeth Goodwin, Colin Green, Annie Hawton
Applied Health Economics and Health Policy
|
May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis
Annie Hawton, James Shearer, Elizabeth Goodwin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 15, 2019
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN)
Annie Hawton, Colin Green, Elizabeth Goodwin, et al.
Social Science & Medicine (1982)
|
June 25, 2021
What drives differences in preferences for health states between patients and the public? A qualitative investigation of respondents' thought processes
Elizabeth Goodwin, Antoinette Davey, Colin Green, et al.
Applied Health Economics and Health Policy
|
October 20, 2017
Involving Members of the Public in Health Economics Research: Insights from Selecting Health States for Valuation to Estimate Quality-Adjusted Life-Year (QALY) Weights
Elizabeth Goodwin, Kate Boddy, Lynn Tatnell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 2026
Measuring health-related quality of life in multiple sclerosis: comparing the acceptability, validity and responsiveness of the EQ-5D-3L and MSIS-8D
Elizabeth Goodwin, Bernhard Michalowsky, Rod Middleton, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 22, 2016
Health Utilities for Multiple Sclerosis
Annie Hawton, Colin Green
Pharmacoeconomics - Open
|
February 15, 2018
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
Jeff Round, Annie Hawton
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 23, 2017
"Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis
Colin Green, Elizabeth Goodwin, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 17, 2018
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P)
Elizabeth Goodwin, Colin Green, Annie Hawton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 2, 2020
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis
Elizabeth Goodwin, Colin Green, Annie Hawton
Applied Health Economics and Health Policy
|
May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis
Annie Hawton, James Shearer, Elizabeth Goodwin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 15, 2019
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN)
Annie Hawton, Colin Green, Elizabeth Goodwin, et al.
Social Science & Medicine (1982)
|
June 25, 2021
What drives differences in preferences for health states between patients and the public? A qualitative investigation of respondents' thought processes
Elizabeth Goodwin, Antoinette Davey, Colin Green, et al.
Applied Health Economics and Health Policy
|
October 20, 2017
Involving Members of the Public in Health Economics Research: Insights from Selecting Health States for Valuation to Estimate Quality-Adjusted Life-Year (QALY) Weights
Elizabeth Goodwin, Kate Boddy, Lynn Tatnell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 2026
Measuring health-related quality of life in multiple sclerosis: comparing the acceptability, validity and responsiveness of the EQ-5D-3L and MSIS-8D
Elizabeth Goodwin, Bernhard Michalowsky, Rod Middleton, et al.
Page
of 5